![]() |
市场调查报告书
商品编码
1351498
手持式手术器械市场规模 - 按产品(镊子、牵开器、抓握器、手术刀、插管)、按应用(骨科手术、心臟病学、眼科、伤口护理、泌尿科和妇科手术)、按最终用途和预测,2023 年- 2032Hand-held Surgical Instruments Market Size - By Product (Forceps, Retractors, Graspers, Scalpels, Cannulas), By Application (Orthopedic Surgery, Cardiology, Ophthalmology, Wound Care, Urology & Gynecology Surgery), By End-use, & Forecast, 2023 - 2032 |
由于全球老年人口不断增加,对外科手术的需求增加,全球手持手术器械市场在2023年至2032年期间复合年增长率将达到7.4%。
根据世界卫生组织估计,到2030 年,全球六分之一的人口将达到60 岁及以上。由于老年人经常需要医疗干预来解决各种健康问题,人口的成长对手部等医疗设备产生了强劲的需求。- 持有手术器械。此外,新兴经济体不断扩大的医疗保健基础设施以及民众对医疗保健选择的意识不断增强,正在促进更多人获得外科手术,进一步推动市场成长。 COVID-19 大流行也强调了医疗保健准备的重要性,促使医疗机构投资购买最先进的手术设备,包括手持器械,以满足紧急医疗需求。
整个手持式手术器械市场根据产品、应用、最终用途和地区进行划分。
由于微创手术技术的日益普及,到 2032 年,扩张器产品领域的复合年增长率将达到 7.7%。这些器械在各种手术过程中扩张血管、组织或狭窄解剖结构、促进手术进入和减少组织创伤方面发挥着至关重要的作用。随着患者偏好转向微创治疗和更快的恢復时间,对精确、高效的手持式扩张器的需求激增。
2023年至2032年,整形外科应用领域的复合年增长率将达8.3%。这是由于全世界越来越重视整容手术。整形外科医生在整容、隆乳和隆鼻等手术中需要专门的仪器来进行精确和精细的组织操作。此外,材料和人体工学设计的创新正在提高外科医生的能力和成果,从而促进整形外科领域的需求增加。
根据最终用途,由于门诊和门诊护理环境的成长趋势,诊所部分在 2023 年至 2032 年间将呈现 6.8% 的复合年增长率。诊所越来越多地在现场进行各种小型外科手术,为患者提供更方便且更具成本效益的选择。这些程序通常需要专门的手持式仪器来精确有效地执行,导致需求不断增长。此外,向基于价值的医疗保健模式的转变正在鼓励诊所投资高品质的仪器,这些仪器可以改善患者的治疗效果并降低整体护理成本,从而进一步推动诊所的需求。
从地区来看,到2032 年,亚太地区手持式手术器材产业的复合年增长率将达到8.5%。蓬勃发展的医疗旅游业是一个重要推动因素,来自世界各地的患者在印度、泰国等国家寻求负担得起的高品质手术治疗和马来西亚。此外,该地区与生活方式相关的疾病(例如肥胖症和糖尿病)日益流行,也提高了手术干预率。中国和印度等国家先进医疗技术的采用和医疗基础设施的扩张也是推动亚太地区市场成长的关键因素。
Global hand-held surgical instruments market will record a 7.4% CAGR between 2023-2032, owing to the rising global geriatric population which is increasing the demand for surgical procedures.
According to estimates from the WHO, one out of six people worldwide will be aged 60 years and over by 2030. As elderly individuals often require medical interventions for various health issues, this increase in population is creating a strong demand for medical equipment such as hand-held surgical instruments. Additionally, the expanding healthcare infrastructure in emerging economies and the growing awareness of healthcare options among the populace are fostering greater access to surgical procedures, further propelling market growth. The COVID-19 pandemic has also underscored the importance of healthcare preparedness, prompting healthcare facilities to invest in state-of-the-art surgical equipment, including hand-held instruments, to address urgent medical needs.
The overall hand-held surgical instruments market is divided based on product, application, end-use, and region.
The dilators product segment will register a 7.7% CAGR through 2032, due to the growing prevalence of minimally invasive surgical techniques. These instruments play a crucial role in dilating blood vessels, tissues, or narrow anatomical structures during various procedures, facilitating access and reducing tissue trauma. As patient preferences shift towards less invasive treatments with quicker recovery times, the need for precise and efficient hand-held dilators has surged.
The plastic surgery application segment will record an 8.3% CAGR over 2023-2032. This is due to the growing emphasis on cosmetic procedures worldwide. Plastic surgeons require specialized instruments for precision and delicate tissue manipulation during surgeries like facelifts, breast augmentation, and rhinoplasties. Moreover, innovations in materials and ergonomic designs are enhancing surgeons' abilities and outcomes, contributing to the heightened demand in the field of plastic surgery.
Based on end-use, the clinics segment will exhibit a 6.8% CAGR between 2023-2032, due to the growing trend towards outpatient and ambulatory care settings. Clinics are increasingly performing a wide range of minor surgical procedures on-site to offer patients more convenient and cost-effective options. These procedures often require specialized hand-held instruments for precise and efficient execution, contributing to the rising demand. Furthermore, the shift towards value-based healthcare models is encouraging clinics to invest in high-quality instruments that can enhance patient outcomes and reduce the overall cost of care, further driving demand in clinic settings.
Regionally, the Asia Pacific hand-held surgical instruments industry will witness an 8.5% CAGR through 2032. One significant driver is the burgeoning medical tourism industry, with patients from around the world seeking affordable and high-quality surgical treatments in countries like India, Thailand, and Malaysia. Additionally, the increasing prevalence of lifestyle-related diseases in this region, such as obesity and diabetes, is boosting surgical intervention rates. The adoption of advanced healthcare technologies and the expansion of healthcare infrastructure in countries like China and India are also pivotal factors driving the market's growth in the Asia Pacific.